Pharmaceutical companies Boehringer Ingelheim and Gilead Sciences are freezing the prices of their antiretroviral drugs for select agencies in the U.S..."We urge the other drug companies to follow [Boehringer's] and Gilead's lead and to freeze price increases…that keep lifesaving drugs out of reach for those who need them," [AIDS Healthcare Foundation] President Michael Weinstein said…Reponses from Abbott Laboratories, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Pfizer, Roche and Johnson & Johnson subsidiary Tibotec Therapeutics "reiterated the companies' commitment to increasing access but made no specific pledge with regard to" price freezes…